penicillamine has been researched along with oxidopamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Correa, JG; Stoppani, AO | 1 |
Bai, SK; Billiar, TR; Chung, HT; Ha, KS; Kim, KM; Kim, PK; Kim, YM; Kwon, YG; Nam, WD; Yoo, YM | 1 |
2 other study(ies) available for penicillamine and oxidopamine
Article | Year |
---|---|
Catecholamines enhance dihydrolipoamide dehydrogenase inactivation by the copper Fenton system. Enzyme protection by copper chelators.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Binding Sites; Captopril; Catecholamines; Catechols; Cattle; Chelating Agents; Copper; Cysteine; Dihydrolipoamide Dehydrogenase; Dopamine; Epinephrine; Hydrogen Peroxide; Hydroxyl Radical; Iron; Kinetics; Mammals; Norepinephrine; Oxidation-Reduction; Oxidopamine; Penicillamine | 1996 |
Nitric oxide prevents 6-hydroxydopamine-induced apoptosis in PC12 cells through cGMP-dependent PI3 kinase/Akt activation.
Topics: Anilides; Animals; Apoptosis; Caspase 3; Caspases; Cell Differentiation; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cytochrome c Group; Cytoprotection; Enzyme Activation; Neurons; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Oligopeptides; Oxidopamine; PC12 Cells; Penicillamine; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Transfection | 2003 |